Gå direkte til innhold
 

Vaccination research 2008 part II: Norwegian-Indian joint call

A total of up to 30 mill. NOK (6 mill. USD) is available from the Research Council of Norway (RCN), and matched funding from Department of Biotechnology (DBT), India, for the period 2009-2011 to support joint Norwegian-Indian researcher projects and user-driven innovation projects.

Forskerprosjekt Velg
Brukerstyrt innovasjonsprosjekt Velg
Søknadsfrist:
03.09.2008 12:00 CEST

Status:

Gjennomført

Antatt tilgjengelige midler:

The call "Vaccination research 2008" consists of two parts:

- part I: General call: a total of up to 70 mill. NOK* or 14 mill. USD is available from the Research Council of Norway

- part II: Joint Norwegian-Indian call: a total of approximately 30 mill. NOK* or 6 mill. USD is available from the Research Council of Norway, and matched funding is available from Department of Biotechnology, India

*The Research Council of Norway will conduct a joint evaluation of proposals submitted under the two parts based upon similar criteria of quality and relevance. The resulting allocations to the two parts could therefore differ from what is indicated above.

Application deadline is September 3rd 2008, 12:00 hrs (noon), Norwegian time.

Project start date is January 1st 2009 at the earliest. Projects should normally run for 3 years, and be completed by December 31st 2011 at the latest.

Føringer og viktige forhold for alle søknadstyper i utlysningen:


The following guidelines apply to “Vaccination research 2008 part II – joint Norwegian-Indian call”. (Please see separate call text for “Vaccination research 2008 part I – general call”).

PREAMBLE

The Department of Biotechnology (DBT), Ministry of Science & Technology, Govt. of India and The Research Council of Norway (RCN) have established collaborative efforts between India and Norway in the field of human vaccination research, including joint calls for proposals and joint research projects between Indian and Norwegian scientists.

This collaboration is based upon early key meetings between Indian and Norwegian stakeholders in Bergen and New Delhi during 2006, that yielded a Roadmap on Indo-Norwegian collaboration in vaccination research. The roadmap set out guiding principles for this collaboration, but the joint calls for proposals are not limited to those institutions or companies mentioned in this document. The collaboration on human vaccination research is now part of the Programme for Global Health Research (GLOBVAC) as described in the The embedded asset has been deleted:
Asset Type: Vedlegg_flex
Asset Id: 1215006708532
PAGENAME: ForskningsradetEngelsk/Vedlegg_flex/Vedlegg_TittelLenke
.

Accordingly, proposals from investigators-driven research initiatives with interactive collaborative efforts across institutions and disciplines in areas of human vaccination research are invited. Both RCN and DBT will provide matched financial support to promote the development of the vaccination sector in India and Norway. This will also create a foundation on which the two countries may cooperate on marketing new discoveries and related product/process development. Collaborative research components may comprise both basic and applied research. This call will include researcher projects but also business and industry involvement through user-driven innovation projects. This initiative would ensure the implementation of projects that encompass collaboration between different institutions and disciplines, with a view to promote optimal knowledge, skill development and appropriate platform for technology promotion and dissemination to the end users benefiting both countries.



THEMATIC GUIDELINES

The proposal must be within the field of global vaccination research, which is here defined as research aiming at providing existing and improved vaccines for marginalized populations, especially children, in low- and middle-income countries. This includes epidemiological studies, the development and evaluation of new or improved vaccines, implementation of vaccination strategies, and studies to measure the costs and outcomes of such strategies.

This call will encourage, but is not restricted to, proposals focusing on:

  • diseases and health problems that account for a large proportion of the global disease burden
  • diseases and health problems that are neglected
  • thematic areas where Norway and India are strongly involved in health programmes and research
  • thematic areas where Norway and India have the capacity and competence to be in the international forefront
  • thematic areas where synergy effects between Norway and India can be expected

Examples of relevant thematic areas are HIV/AIDS, respiratory and enteric infections, tuberculosis, influenza, meningococcal disease and human papilloma virus.

The following types of studies are included in this call:

  • development of diagnostic tools, and identification of the need for vaccination programmes based on epidemiological studies
  • development of new candidate vaccines and identification of optimal formulations and immunization regimens for new and existing vaccines
  • development of methods to assess vaccine-induced protection (immune correlates), toxicity and side-effects
  • determination of the impact of vaccination, including protective efficacy and effectiveness for relevant outcome parameters and the development of national surveillance systems
  • increasing the availability and ensuring equitable coverage of existing vaccines
  • stimulation of technology transfer to low- and middle-income countries, including improved strategies for cost-effective production of vaccines and the development of trial sites


GENERAL GUIDELINES

How to apply
The Norwegian and Indian collaborating investigators are required to prepare a joint application for the main research project. Applications should be submitted to both the RCN and the DBT. The applications to RCN should be submitted via the eSøknad electronic application system. The applications to the DBT should be submitted electronically (6 copies also by post) on Indian application form, to Mr. S. Sinha: 
ssinha.dbt@gmail.com(DBT website: www.dbtindia.nic.in).

All relevant points of the application forms must be completed. The application to the RCN and to DBT should contain an identical project description, describing both the Indian and the Norwegian activities in the project, an overview of proposed annual and overall expenses associated with Norwegian and Indian project activities as well as a funding plan specifying Norwegian and Indian funding sources respectively. All applications submitted to the RCN will be subject to the Council's general rules regarding the application types in question and the DBT will follow its own norms and procedures.

Time line and budget
Projects should run over a period of 3 years, and must be completed by the end of 2011. The Indian side will initially grant funding for a period of 3 years, with the possibility for a one year extension. Earliest possible start of projects is
 January 1st 2009. The Research Council of Norway will fund the activities proposed by the Norwegian investigator(s), while costs proposed by the Indian investigator(s) will be provided by the Department of Biotechnology (DBT), India. Proposals should have annual budgets of 1-5 mill. NOK (0.2 – 1 mill. USD) from the RCN, and matched funding from the DBT.

Proposal submission  
For the Indian side, proposals should be sent to S. Sinha, Adviser, Department of Biotechnology, Block-II, CGO Complex, Lodhi Road, New Delhi 110003 by e-mail (
ssinha.dbt@gmail.com) and also by post (6 copies). For further queries/clarifications, please contact at Tel. 011-24363760. Website: www.dbtindia.nic.in.

For the Norwegian side, proposals should be submitted using the electronic application form “e-Søknad” (choose application form, confirm the acceptance of conditions, and click “Create new application” at the top of this page). The following specific guidelines apply:

The application and project description (a maximum of 10 pages, font Times New Roman 12 point, footnotes and references included) must be well structured and clearly written in English

  • Activities should be clearly described according to a timeline, and could be organized into work packages when appropriate
  • Milestones should be identified that can be used to easily follow the progress of the project.
  • Budget information should be detailed and clearly presented, and should, when necessary, be specified in the project description or in a separate attachment
  • Proposals should include considerations on ethics, capacity building and sustainability
  • All international cooperation must be documented

The deadline for submission is September 3rd 2008, 12:00 hrs (noon), Norwegian time


Review process

All grant applications will be assessed for scientific merit by international referees. The RCN and the DBT will jointly select up to five international experts, and the RCN is responsible for circulating joint applications to the experts for review. The RCN's forms and guidelines for international review of grant proposals will be utilised in the assessment process. Subsequently, the applications and the review comments will be presented to the decision-making bodies in
 Norway (the Programme Board for Global Health and Vaccination Research, GLOBVAC) and India (DBT). The decision-making bodies will evaluate the scientific merit, utility and relevance of the proposals, and are responsible for allocating funds / denying funds to their own country’s part of the application. Agreement among the decision-making bodies of the two countries is a prerogative for funding common projects.


Award criteria
The main criteria for award decision will primarily include the following:

  1. Scientific merit of the project
  2. Expertise with the Principal Investigator(s) and networking/collaborating team
  3. Competence to enter into collaborative arrangements
  4. Availability of core infrastructure and support facilities to carry out the proposed project at host institute(s)
  5. Utility and relevance (for the guidelines of this call)
  6. Strategic use of the funding and the probability for success

Specific criteria are mentioned in the guidelines for each application type.


Additional information

Contracts
The RCN will enter into a contract with the Norwegian applicant for the Norwegian share of the project. Likewise, DBT will enter into a contract with the Indian applicant for the Indian share of the project.

Agreement on rights to and use of findings
Before entering into a contract, the concerned parties shall sign a consortium agreement specifying the rights to and use of findings (IPR) in consultation with DBT and RCN.


Time line
Receipt of Proposals: September 3rd, 2008

Award decision:   December, 2008
Award notification:   December, 2008


GUIDELINES FOR NORWEGIAN PARTNERS:

Eligible applicants are public and private Norwegian institutions. Allocation of funds must contribute to developing high quality projects with participation of Norwegian research groups and/or institutions.

International collaboration is encouraged, including partnerships with low- and middle-income countries. Funding from the programme can be spent overseas. International research groups or institutions can access funding from the programme as partners on proposals from Norwegian public or private institutions. Proposals must define tasks and funding for each of the international collaborators of the project.

Capacity building: It should be demonstrated that the project can lead to research capacity building in Norway and, when applicable, amongst collaborative partners in low- and middle-income countries.

Budget: Projects should have budgets with 1-5 million NOK annually funded from the GLOBVAC programme. Projects are encouraged to secure additional funding from other sources (eg. EU-funding, own funding). Further, projects with own/additional funding and projects that can demonstrate sustainable commitments from own institution or other sources during and/or beyond the project period are encouraged. It is recommended that partners/staff in low- and middle-income countries are paid according to local salary levels.

The scope of the project should be realistic within the time frame and budget limitations of the project.

Participation of master and PhD students and post doctoral fellows should be integral components of a larger project proposal. Proposals consisting of an individual fellowship only will not be given priority.

Scientific results should be made available to all partners in the project. It is strongly encouraged to publish in peer-review journals that are accessible to scientists in low- and middle-income countries if possible.

Se også

Andre nettsider